MetLife Investment Management, LLC - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 128 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$73,600
-8.1%
49,7300.0%0.00%0.0%
Q2 2023$80,065
-44.5%
49,7300.0%0.00%0.0%
Q1 2023$144,217
+21.9%
49,730
+37.9%
0.00%0.0%
Q4 2022$118,319
-33.8%
36,073
-23.7%
0.00%
-50.0%
Q3 2022$178,756
-45.5%
47,290
+12.3%
0.00%
-33.3%
Q2 2022$328,006
-24.4%
42,106
-9.8%
0.00%0.0%
Q1 2022$433,685
-7.5%
46,683
+56.9%
0.00%
-25.0%
Q4 2021$468,907
-12.0%
29,7530.0%0.00%
-20.0%
Q3 2021$532,579
+15.1%
29,7530.0%0.01%
+25.0%
Q2 2021$462,659
+8.3%
29,7530.0%0.00%0.0%
Q1 2021$427,253
-26.8%
29,7530.0%0.00%
-33.3%
Q4 2020$584,051
+51.5%
29,7530.0%0.01%
+50.0%
Q3 2020$385,599
-11.1%
29,7530.0%0.00%
-20.0%
Q2 2020$433,501
+114.3%
29,753
+25.2%
0.01%
+66.7%
Q1 2020$202,300
-48.3%
23,7720.0%0.00%
-25.0%
Q4 2019$391,525
+16.6%
23,7720.0%0.00%0.0%
Q3 2019$335,661
-11.4%
23,772
+26.2%
0.00%0.0%
Q2 2019$378,812
-49.4%
18,8370.0%0.00%
-50.0%
Q1 2019$748,771
+14.4%
18,8370.0%0.01%0.0%
Q4 2018$654,397
-16.0%
18,8370.0%0.01%0.0%
Q3 2018$778,910
+12.6%
18,8370.0%0.01%0.0%
Q2 2018$692,000
+17.9%
18,837
+25.1%
0.01%
+14.3%
Q1 2018$587,000
+170.5%
15,056
+25.9%
0.01%
+250.0%
Q4 2017$217,00011,9630.00%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Antipodean Advisors LLC 1,000,000$3,280,00010.95%
M28 Capital Management LP 439,300$1,440,9041.37%
Redmile Group, LLC 6,242,756$20,476,2400.84%
MAVERICK CAPITAL LTD 6,291,013$20,634,5230.49%
Baupost Group 8,123,616$26,6450.44%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 52,000$1710.25%
WASATCH ADVISORS LP 8,391,014$27,522,5250.18%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 525,000$1,722,0000.17%
STALEY CAPITAL ADVISERS INC 450,000$1,4760.09%
Virtus ETF Advisers LLC 36,100$118,4080.06%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders